Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Has results × Alpelisib × Clear all

Status

Sponsor Class

Study Type

Interventional 13 Observational 1

Sponsor

Conditions

Hereditary Sensory and Autonomic Neuropathies 1

Interventions

Sunitinib 14 exemestane 11 Afatinib 10 palbociclib 9 Rituximab 8 Leuprolide 8 Bevacizumab 8 Erlotinib Hydrochloride 7 Letrozole 6 enzalutamide 5 Surveys and Questionnaires 5 Standard of Care 5 Drug Therapy 5 Capecitabine 5 Blood Specimen Collection 5 lorlatinib 4 Trastuzumab 4 Docetaxel 4 Crizotinib 4 Aromatase Inhibitors 4 Anastrozole 4 Abiraterone Acetate 4 talazoparib 3 osimertinib 3 avelumab 3 apalutamide 3 Tyrosine Kinase Inhibitors 3 Surgical Procedures, Operative 3 Radiotherapy 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04285723 2023-02-09

EPIK-P1

Novartis

57 enrolled 23 charts 1 FDA

Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡